Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery.

scientific article published on 23 March 2011

Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10147-011-0223-5
P698PubMed publication ID21431342

P50authorAkihiro TakedaQ53539115
P2093author name stringFumitaka Kikkawa
Tetsuro Nagasaka
Satoyo Hosono
Hiroaki Kajiyama
Michiyasu Kawai
Katsuji Matsuzawa
Kimio Mizuno
Katsumi Sakakibara
P2860cites workCytoreductive surgery for advanced stages of ovarian cancerQ33959827
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group StudyQ34008331
Identification of prognostic factors in advanced epithelial ovarian carcinomaQ34344858
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group StudyQ36912591
Clinicopathological characteristics of mucinous adenocarcinoma of the ovaryQ37411776
Stage IV ovarian cancer: impact of surgical debulkingQ41313986
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancerQ41610690
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experienceQ46974757
Reproducibility of tumor measurements in ovarian cancer: a study of interobserver variability.Q52881651
A critique of surgical cytoreduction in advanced ovarian cancer.Q52925628
Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.Q53291742
Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experienceQ67989907
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaQ72382597
The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancerQ72644277
Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective studyQ73923094
Long-term results and prognostic factors in patients with epithelial ovarian cancerQ73938099
Trends in the mortality (1950-1997) and incidence (1975-1993) of malignant ovarian neoplasm among Japanese women: analyses by age, time, and birth cohortQ74590454
Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)Q81297573
P433issue5
P921main subjectovarian cancerQ172341
ovarian carcinomaQ18556145
P304page(s)524-532
P577publication date2011-03-23
P1433published inInternational Journal of Clinical OncologyQ15758148
P1476titleComparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery
P478volume16

Reverse relations

cites work (P2860)
Q37017000Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer
Q58763140Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience
Q64053341Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
Q60046966The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer